1391 Results

People

  1. Vickers
    Vickers
  2. Adusumilli
    Adusumilli
  3. Marghoob
    Marghoob
  4. Scordo
    Scordo
  5. Levine
    Levine
  6. Saltz
    Saltz
  7. Cheung
    Cheung
  8. Ladanyi
    Ladanyi
  9. Lee
    Lee
  10. Abramson
    Abramson

Groups

  1. Department of Medicine (456)
  2. Surgery (266)
  3. Survivorship Research (205)
  4. Population Sciences Research Program (201)
  5. Solid Tumor Oncology Division (179)
  6. Center for Hematologic Malignancies (171)
  7. Epidemiology and Biostatistics (171)
  8. Hematologic Malignancies, Division of (170)
  9. GSK Faculty (152)
  10. Division of Subspecialty Medicine (146)
  1. "letter"
Formats
  1. Journal Article (990)
  2. Correspondence (221)
  3. Research Letter (168)
  4. Editorial (10)
  5. Miscellaneous (1)
  6. Review (1)
Groups
  1. Department of Medicine (456)
  2. Surgery (266)
  3. Survivorship Research (205)
  4. Population Sciences Research Program (201)
  5. Solid Tumor Oncology Division (179)
  6. Center for Hematologic Malignancies (171)

More Groups

People
  1. Andrew Vickers (46)
  2. Ashfaq Marghoob (18)
  3. Michael Scordo (18)
  4. Peter Bach (18)
  5. Prasad Adusumilli (18)
  6. Leonard Saltz (17)

More People

Years
  1. 2025 (45)
  2. 2024 (105)
  3. 2023 (67)
  4. 2022 (63)
  5. 2021 (32)
  6. 2020 (69)

More Years

Publications
  1. Journal of Clinical Oncology (118)
  2. New England Journal of Medicine (92)
  3. International Journal of Radiation Oncology, Biology, Physics (50)
  4. European Urology (33)
  5. JNCI: Journal of the National Cancer Institute (32)
  6. Leukemia and Lymphoma (32)

More Publications

Publishers
  1. Elsevier Inc. (154)
  2. Elsevier Science, Inc. (130)
  3. American Society of Clinical Oncology (120)
  4. Nature Publishing Group (98)
  5. Lippincott Williams & Wilkins (95)
  6. Massachusetts Medical Society (92)

More Publishers

Results (1391)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pediatric colloid cysts
    Correspondence

    Giantini-Larsen, A. M.; Uribe-Cardenas, R.; Villamater, F. N.; Garton, A. L. A.; Souweidane, M. M.
    Journal of Neurosurgery-Pediatrics (2022)

    Fulltext@MSK | Save
  • Interpreting nonrandomized clinical trial data in low-grade sarcoma: Differentiating clinical benefit from indolent disease is key
    Correspondence

    Rosenbaum, E.; Movva, S.; Kelly, C.
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Reply
    Correspondence

    Gausman, V.; Liang, P. S.; Du, M.
    Gastroenterology (2022)

    Fulltext@MSK | Save
  • Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
    Research Letter

    Stuver, R.; Shah, G. L.; Korde, N. S.; Roeker, L. E.; Mato, A. R.; Batlevi, C. L.; Chung, D. J.; Doddi, S.; Falchi, L.; Gyurkocza, B.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save
  • In reply to Qureshi et al
    Correspondence

    Hesse, J.; Zakeri, K.; Lee, N. Y.
    Advances in Radiation Oncology (2022)

    Fulltext@MSK | Save
  • Image consent and the development of image-based artificial intelligence - In reply
    Correspondence

    Daneshjou, R.; Rotemberg, V.; for the International Skin Imaging Collaboration Artificial Intelligence Working Group
    JAMA Dermatology (2022)

    Fulltext@MSK | Save
  • Facial subcutaneous dermatofibrosarcoma protuberans treated with imatinib and monitored with magnetic resonance: A therapeutic alternative for unresectable cases
    Research Letter

    Navarrete-Dechent, C.; Shah, K.; Mori, S.; Gounder, M. M.; Stambuk, H. E.; Nehal, K. S.
    Dermatologic Therapy (2022)

    Fulltext@MSK | Save
  • Highly favorable outcomes with salvage radiation therapy and autologous hematopoietic cell transplantation in relapsed and refractory DLBCL patients with minimal to no response to salvage chemotherapy
    Research Letter

    Yang, J. C.; Scordo, M.; Chau, K. W.; Sauter, C. S.; Yahalom, J.
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience
    Research Letter

    Mohan, M.; Becnel, M. R.; Shah, U. A.; Dong, H.; Gundarlapalli, S.; Peterson, T.; Orozco, J. S.; Horowitz, S.; Chhabra, S.; Dhakal, B.; more...
    American Journal of Hematology (2022)

    Fulltext@MSK | Save
  • Crossing survival curves of KEYNOTE-177 illustrate the rationale behind combining immune checkpoint inhibition with chemotherapy – Authors' reply
    Correspondence

    André, T.; Diaz, L. A. Jr; Shiu, K. K.
    Lancet Oncology (2022)

    Fulltext@MSK | Save